Life Sciences/Animal Health and Research

Clinical trial testing begins at KU Medical Center for those with mild COVID-19 symptoms

A new study has begun at the University of Kansas Medical Center as it started clinical trials for a new COVID-19 treatment Tuesday. The new treatment aims to help infected individuals with mild COVID-19 symptoms that have not been hospitalized… more

The 2020 Ingram’s 250

Time for some Ingram’s 250 math: What’s i250 x 5? If you came up with 1,250, hats off to your grade-school math teachers—their lessons clearly took hold. But with this being the fifth year of our recognition of the 250… more

Coping with COVID: AstraZeneca vaccine trials resume

Last week a large, international AstraZeneca COVID-19 vaccine trial was halted due to reports of a strong adverse effect in a participant, thought to be due to the vaccine. This week, the vaccine trial has resumed in the U.K., though… more

Coping with COVID: AstraZeneca COVID-19 vaccine study paused after one illness

AP – Late-stage studies of AstraZeneca’s COVID-19 vaccine candidate are on temporary hold while the company investigates whether a recipient’s “potentially unexplained” illness is a side effect of the shot. In a statement issued Tuesday evening, the company said its,… more

Coping with COVID: Clinical Reference Laboratory in Lenexa increases testing

One Kansas City metro facility has been hard at work processing COVID-19 samples, working with a different kind of sampling process that collects saliva rather than swabs. Lenexa-based Clinical Reference Laboratory has been testing around 6,000 saliva samples every day,… more

Thermo Fisher in Lenexa opens new site to help increase coronavirus testing

In an announcement made by Kansas Gov. Laura Kelly on Friday, the Thermo Fisher Scientific in Lenexa has opened a new site will help increase the amount of statewide testing. Named the Viral Transport Media manufacturing site, the additional facility… more

Missouri coronavirus saliva test approved by FDA

COLUMBIA, Mo. (AP) — A Washington University saliva test for the coronavirus has been approved by the Food and Drug Administration (FDA), Missouri Gov. Mike Parson announced Wednesday. The St. Louis-area university worked with biotechnology company Fluidigm to develop the… more

Coping with COVID: Second vaccine by Pfizer and BioNTech shows fewer side effects

Plans for a large-scale trial to be conducted with Pfizer and BioNTech’s first vaccine (referred to as B1) were soon altered, the companies instead conducting the trial using a second vaccine, called B2. On July 1, the companies presented data… more

Coping with COVID: Study finds that blood plasma from patients post-COVID-19 can help treat others

A study involving over 35,000 patients with COVID-19 showed improvement among severe patients after they were infused with blood plasma from individuals who had recovered from the virus. The study was conducted by the Mayo Clinic and sponsored by the… more

KU Alzheimer’s Disease Center researchers make progress with drug

At KU’s Alzheimer's Disease Center, researchers reveal some positive findings from a drug used to treat Alzheimer's. The drug is called glutothyone and although it has only been used in the lab so far, Director of the KU Alzheimer's Disease… more